H M Shepard Selected Research

NB1011

3/2001	A novel approach to thymidylate synthase as a target for cancer chemotherapy.
1/2001	Enzyme-catalyzed therapeutic agent (ECTA) design: activation of the antitumor ECTA compound NB1011 by thymidylate synthase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H M Shepard Research Topics

Disease

3	Neoplasms (Cancer) 01/2008 - 01/2001
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2013
1	Adenocarcinoma 01/2013
1	Breast Neoplasms (Breast Cancer) 01/2008
1	Communicable Diseases (Infectious Diseases) 01/2001
1	Colorectal Neoplasms (Colorectal Cancer) 01/2001

Drug/Important Bio-Agent (IBA)

2	EnzymesIBA 03/2001 - 01/2001
2	NB1011IBA 03/2001 - 01/2001
2	Thymidylate SynthaseIBA 03/2001 - 01/2001
1	Hyaluronic Acid (Hyaluronan)IBA 01/2013
1	Pharmaceutical PreparationsIBA 01/2013
1	Phosphotransferases (Kinase)IBA 01/2008
1	Monoclonal AntibodiesIBA 01/2008
1	Epidermal Growth Factor (EGF)IBA 01/2008
1	Trastuzumab (Herceptin)FDA Link 01/2008
1	Tyrosine (L-Tyrosine)FDA Link 01/2008
1	phosphoramidic acidIBA 03/2001
1	brivudine (brivudin)IBA 03/2001
1	raltitrexed (D 1694)IBA 03/2001
1	Proteins (Proteins, Gene)FDA Link 03/2001
1	Messenger RNA (mRNA)IBA 03/2001
1	Fluorouracil (Carac)FDA LinkGeneric 01/2001

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 03/2001 - 01/2001